Comparative Efficacy and Acceptability of Antiepileptic Drugs for Classical Trigeminal Neuralgia: a Bayesian Network Meta-analysis Protocol

Overview

Journal BMJ Open

Specialty General Medicine

Date 2018 Jan 24

PMID 29358420

Citations 7

Authors

Zongshi Qin

Shang Xie

Zhi Mao

Yan Liu

Jiani Wu

Toshi A Furukawa

Joey S W Kwong

Jinhui Tian

Zhishun Liu

Affiliations

Soon will be listed here.

Abstract

Introduction: Trigeminal neuralgia (TN) affects 4 to 28.9/100 000 people worldwide, and antiepileptic drugs such as carbamazepine and oxcarbazepine are the firstline treatment options. However, the efficacy and safety of other antiepileptic drugs remain unclear due to insufficient direct comparisons.

Objective: To compare the efficacy and acceptability of all currently available antiepileptic agents for the treatment of patients with classical TN.

Methods: We will search the PubMed, EMBASE, Cochrane Library and Web of Science databases for unpublished or undergoing research listed in registry platforms. We will include all randomised controlled trials comparing two different antiepileptic drugs or one antiepileptic drug with placebo in patients with classical TN. The primary outcomes will be the proportion of responders and the number of subjects who dropout during the treatment. The secondary outcomes will include the two primary outcomes but in the follow-up period, changes in the self-reporting assessment scale for neuralgia and quality of life assessment. In terms of network meta-analysis, we will fit our model to a Bayesian framework using the JAGS and pcnetmeta packages of the R project.

Ethics And Dissemination: This protocol will not disseminate any private patient data. The results of this review will be disseminated through peer reviewed publication.

Prospero Registration Number: CRD42016048640.

Citing Articles

Oral pharmacological treatments for chronic prostatitis/chronic pelvic pain syndrome: A systematic review and network meta-analysis of randomised controlled trials.

Qin Z, Zhang C, Guo J, Kwong J, Li X, Pang R EClinicalMedicine. 2022; 48:101457.

PMID: 35706494 PMC: 9125656. DOI: 10.1016/j.eclinm.2022.101457.

Trigeminal Neuralgia: Current Approaches and Emerging Interventions.

Xu R, Xie M, Jackson C J Pain Res. 2021; 14:3437-3463.

PMID: 34764686 PMC: 8572857. DOI: 10.2147/JPR.S331036.

Unveiling the comparative efficacy and tolerability of comprehensive treatments for migraine: A protocol of systematic review and Bayesian network meta-analysis.

Jin B, Liu H, Qiao L Medicine (Baltimore). 2021; 100(4):e24083.

PMID: 33530202 PMC: 7850759. DOI: 10.1097/MD.0000000000024083.

A simple mechanistic terminology of psychoactive drugs: a proposal.

Seifert R, Schirmer B Naunyn Schmiedebergs Arch Pharmacol. 2020; 393(8):1331-1339.

PMID: 32535698 PMC: 7351828. DOI: 10.1007/s00210-020-01918-x.

Efficacy and Safety of Percutaneous Ozone Injection Around Gasserian Ganglion for the Treatment of Trigeminal Neuralgia: A Multicenter Retrospective Study.

Gao L, Chen R, Williams J, Li T, Han W, Zhao Q J Pain Res. 2020; 13:927-936.

PMID: 32440198 PMC: 7210028. DOI: 10.2147/JPR.S232081.

References

Zakrzewska J, Lopez B, Kim S, Coakham H . Patient reports of satisfaction after microvascular decompression and partial sensory rhizotomy for trigeminal neuralgia. Neurosurgery. 2005; 56(6):1304-11. DOI: 10.1227/01.neu.0000159883.35957.e0. View

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 350:g7647. DOI: 10.1136/bmj.g7647. View

Dworkin R, Turk D, Farrar J, Haythornthwaite J, Jensen M, Katz N . Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2004; 113(1-2):9-19. DOI: 10.1016/j.pain.2004.09.012. View

Katusic S, Beard C, Bergstralh E, Kurland L . Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990; 27(1):89-95. DOI: 10.1002/ana.410270114. View

Mueller D, Obermann M, Yoon M, Poitz F, Hansen N, Slomke M . Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia. 2011; 31(15):1542-8. DOI: 10.1177/0333102411424619. View

McQuay H, Carroll D, Jadad A, Wiffen P, Moore A . Anticonvulsant drugs for management of pain: a systematic review. BMJ. 1995; 311(7012):1047-52. PMC: 2551361. DOI: 10.1136/bmj.311.7012.1047. View

FROMM G, TERRENCE C, Chattha A . Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984; 15(3):240-4. DOI: 10.1002/ana.410150306. View

Devor M, Amir R, Rappaport Z . Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain. 2002; 18(1):4-13. DOI: 10.1097/00002508-200201000-00002. View

MacDonald B, Cockerell O, Sander J, Shorvon S . The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain. 2000; 123 ( Pt 4):665-76. DOI: 10.1093/brain/123.4.665. View

10.

Campbell F, Graham J, ZILKHA K . Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966; 29(3):265-7. PMC: 496031. DOI: 10.1136/jnnp.29.3.265. View

11.

Baker S, Kramer B . The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C?. BMC Med Res Methodol. 2002; 2:13. PMC: 137603. DOI: 10.1186/1471-2288-2-13. View

12.

Qin Z, Li B, Wu J, Tian J, Xie S, Mao Z . Acupuncture for chronic diarrhea in adults: Protocol for a systematic review. Medicine (Baltimore). 2017; 96(4):e5952. PMC: 5287965. DOI: 10.1097/MD.0000000000005952. View

13.

Wiffen P, McQuay H, Moore R . Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005; (3):CD005451. DOI: 10.1002/14651858.CD005451. View

14.

Zakrzewska J, Linskey M . Trigeminal neuralgia. BMJ Clin Evid. 2014; 2014. PMC: 4191151. View

15.

Yuan M, Zhou H, Xiao Z, Wang W, Li X, Chen S . Efficacy and Safety of Gabapentin vs. Carbamazepine in the Treatment of Trigeminal Neuralgia: A Meta-Analysis. Pain Pract. 2016; 16(8):1083-1091. DOI: 10.1111/papr.12406. View

16.

Zakrzewska J, Patsalos P . Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain. 2002; 95(3):259-266. DOI: 10.1016/S0304-3959(01)00406-7. View

17.

Wiffen P, Rees J . Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev. 2007; (2):CD006044. DOI: 10.1002/14651858.CD006044.pub2. View

18.

Gronseth G, Cruccu G, Alksne J, Argoff C, Brainin M, Burchiel K . Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008; 71(15):1183-90. DOI: 10.1212/01.wnl.0000326598.83183.04. View

19.

Hutton B, Salanti G, Caldwell D, Chaimani A, Schmid C, Cameron C . The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015; 162(11):777-84. DOI: 10.7326/M14-2385. View

20.

DeSouza D, Hodaie M, Davis K . Structural Magnetic Resonance Imaging Can Identify Trigeminal System Abnormalities in Classical Trigeminal Neuralgia. Front Neuroanat. 2016; 10:95. PMC: 5070392. DOI: 10.3389/fnana.2016.00095. View